Expert Rev Mol Diagn. 2023 Jul 4. doi: 10.1080/14737159.2023.2233415. Online ahead of print.
ABSTRACT
OBJECTIVE: To assess the diagnostic accuracy of noninvasive prenatal screening (NIPS) in screening for copy number variations (CNVs).
METHODS: We conducted a systematic review and meta-analysis by combining our study results with those reported in other articles. We retrospectively collected the data of pregnant women with NIPS testing in the Hangzhou Women’s Hospital from December 2019 to February 2022. Simultaneously, a systematic search of PubMed, EMBASE and Web of Science was carried out to identify all relevant peer-reviewed publications. Statistical analysis was performed based on the random-effects model to determine a pooled estimate of the positive predictive value (PPV).
RESULTS: A total of 29 studies involving 2,667 women were included for analysis. The pooled PPV of NIPS in the detection of CNVs was 32.86% (95% confidence interval [24.61-41.64]). Statistical heterogeneity was high, while no significant publication bias was found in this meta-analysis. There were insufficient data to determine sensitivity and specificity accurately, as most studies only performed confirmatory tests on high-risk women.
CONCLUSIONS: The PPV of NIPS in screening for CNVs was approximately 33%. Cautions should be kept in mind for the pretest guidance and subsequent after-test counseling when offering such genome-wide NIPS tests.
PMID:37401569 | DOI:10.1080/14737159.2023.2233415
